Participated · Equity · Jul 2026

Provect AI develops 3D-Anywhere, a software-only solution that reconstructs volumetric 3D images from standard fluoroscopic C-arms used in spine and orthopedic procedures. The product is vendor-agnostic, exports DICOM straight to PACS, and requires no new hardware in the operating room. The company’s commercial strategy is to upgrade hospitals' existing C-arms, converting the installed base into a distribution channel rather than pursuing capital equipment sales. Provect AI secured FDA 510(k) clearance for the product, a milestone the company and investors framed as turning the product into a priced, sellable asset. The team is described as an experienced MedTech group with proven exits.

Participated · Equity · Jun 2026

Haiku is the name of Clerk’s AI-driven legaltech platform designed for law firms and used by roughly 2,000 cabinets. The company positions Haiku to serve the broader French legal market of about 75,000 lawyers and has refocused its branding around the product since 2025. Financially, Clerk raised €1.3M in pre-amorçage the year before and has just secured an additional €3M from Newfund NAEH, Velocity and regional fund Naco. Management, led by president and cofounder Jules Touzet, says the fresh capital will be used to improve the software and accelerate commercial growth in France. The startup is based in Bordeaux and is competing in an increasingly crowded legaltech landscape.

Led · Equity · Jun 2026

Hublo develops a proprietary AI delivered as a SaaS product for the luxury dry-cleaning (pressing) sector to improve operations and traceability. Founded in Paris in 2020, the company offers tiered subscription pricing (promotional 1 € first month, then paid monthly tiers) for its email-based service plans. Following a €1 million equity raise from Newfund, Hublo plans to accelerate commercial deployment across France and expand internationally. The company has set a goal of equipping 9,000 pressings by 2030 to help them meet evolving textile traceability requirements. The articles do not disclose revenue, user counts, or prior funding rounds.

Led · Seed · Apr 2026

Fermeate develops an optogenetics platform that uses light-sensitive proteins and AI-driven light patterns to control gene expression in microbial fermentation processes. The technology can be retrofitted into existing stainless-steel fermenters by recirculating culture through an external light-delivery device, enabling higher and more sustained productivity. Founded in 2024 by Kevin Xu, PhD, and Saurabh Malani, PhD, the company has partnerships with four global food and ingredient companies and reports up to a 200% increase in protein production in under six months, with potential for up to 10x gains. Fermeate has validated its approach on multiple industrial host strains, including conventional and non-conventional yeasts and bacteria. The company is generating revenue through several paid projects while exploring business models and aims to scale its tech to improve capital efficiency across biomanufacturing operations.

Participated · Seed · Dec 2025

Founded in 2020, Kéria offers an AI-powered platform that ingests mortgage-application documents via optical character recognition and instantly evaluates an applicant’s creditworthiness. The tool automates document analysis, pre-qualification, and final decisioning, aiming to replace the manual, paper-heavy workflows still common in mortgage lending. Today the company processes roughly 600 loan files each month, giving lenders faster turnaround times and consumers quicker answers. Kéria’s business model centers on selling this decision-as-a-service technology to banks and lenders that want to digitize underwriting. With fresh capital, management intends to scale the number of applications processed and further enhance its AI models. The firm is led by CEO and co-founder Emilie de Marne and is headquartered in Bordeaux, France. Prior to the current seed round, no previous financing details were disclosed.